Name: | Description: | Size: | Format: | |
---|---|---|---|---|
181.67 KB | Adobe PDF |
Advisor(s)
Abstract(s)
The continuous delivery of a levodopa/carbidopa gel suspension (Duodopa®) into the small bowel through a jejunal tube inserted via percutaneous endoscopic gastrostomy represents a new treatment method in advanced Parkinson disease. Some severe device-related complications have been described in the last few years. Some of them are associated with phytobezoar formation at the pigtail of the catheter. We present the case of a Parkinson disease patient treated with the Duodopa infusion system complicated by jejunal tube fistulization into the colon. We suggest a possible treatment strategy for this complication, which has not been described in the literature to date.
Description
Keywords
HSAC GAS HSAC NEU CHLC CHBPT Antiparkinson Agents Parkinson Disease Gastrointestinal Endoscopy Gastrostomy/adverse effects
Citation
GE Port J Gastroenterol. 2017 May;24(3):147-150
Publisher
Sociedade Portuguesa de Gastrenterologia